1. What happened a year ago this week in biopharma? Regeneron’s Eylea approval, Novartis’ new ethics czar, Vertex’s Kalydeco, and Opidvo’s SCLC approval click to review and read a current update of the big stories from one year ago
    Dismiss Notice
  2. Dealing with a potential legal issue at work?Ask an Employment Attorney -- a chance to discuss employment-related legal issues with a practicing attorney with over 20 years in employment law experience.
    Dismiss Notice

Accountable Care Organization

Discussion in 'Pinnacle Biologics' started by Anonymous, Jun 4, 2013 at 8:17 AM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    This is gaining lots of traction. Today, I was told by a KOL that the ACO model which is being implemented across ALL health systems will put the nail in the coffin for costly procedures such as PDT. Yesterday, the ACO model was thoroughly discussed at a multiple health system conference. Photofrin was on a list of examples for costly non-survival procedures.